Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Cancer Research
|
November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency
Alena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
Human Gene Therapy
|
June 23, 2009
Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting
Neus Bayo-Puxan, Marta Gimenez-Alejandre, Sergio Lavilla-Alonso, et al.
Scientific Reports
|
October 9, 2019
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Marc Garcia-Moure, Naiara Martinez-Velez, Marisol Gonzalez-Huarriz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 3, 2010
Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses
Juan J Rojas, Sonia Guedan, Peter F Searle, et al.
Cancer Research
|
September 7, 2007
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M Alonso, Manel Cascallo, Candelaria Gomez-Manzano, et al.
Plos One
|
January 26, 2016
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Plos One
|
June 10, 2016
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martínez-Vélez, Enric Xipell, Beatriz Vera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 6, 2021
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11
Ana Mato-Berciano, Sara Morgado, María V Maliandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2010
Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors
Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Cancer Research
|
November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency
Alena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
Human Gene Therapy
|
June 23, 2009
Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting
Neus Bayo-Puxan, Marta Gimenez-Alejandre, Sergio Lavilla-Alonso, et al.
Scientific Reports
|
October 9, 2019
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Marc Garcia-Moure, Naiara Martinez-Velez, Marisol Gonzalez-Huarriz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 3, 2010
Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses
Juan J Rojas, Sonia Guedan, Peter F Searle, et al.
Cancer Research
|
September 7, 2007
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M Alonso, Manel Cascallo, Candelaria Gomez-Manzano, et al.
Plos One
|
January 26, 2016
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Plos One
|
June 10, 2016
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Beatriz Vera, Naiara Martínez-Vélez, Enric Xipell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martínez-Vélez, Enric Xipell, Beatriz Vera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 6, 2021
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11
Ana Mato-Berciano, Sara Morgado, María V Maliandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2010
Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors
Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire, et al.
Page
of 3